← Eichor
Study identifier: NCT06788418 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparative Study of SMILE, ICL, and Wavelight Plus Alcon Technologies in Myopia Correction

Condition: Myopia  ·  Sponsor: Beijing Visionly Plus Eye Hospital

PhaseNA
Planned participants1000
Who can joinAll sexes, 18 Years to 40 Years
Healthy volunteersNo

About this study

Myopia is a prevalent refractive error with significant lifestyle impact. While traditional SMILE (Small Incision Lenticule Extraction) and ICL (Implantable Collamer Lens) surgeries are standard options, the advent of the Wavelight Plus Alcon system presents a promising new technique. This trial aims to evaluate the safety, efficacy, and patient satisfaction across these methods.

This description comes directly from the study's public registry record.

Talk to the study team

Peng ZHOU, M.D.  ·  +86-18801871108  ·  drzhoupeng@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Beijing New Vision Eye HospitalBeijing, ChinaRecruiting
Beijing Visionly Plus Eye HospitalBeijing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06788418